ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628676 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628676; 2) Community: the network communities that were significantly associated with the response to NSC 628676; 3) Molecule: the relationships between components within communities and NSC 628676; 4) MDR: the compounds that were significantly associated with the NSC 628676.

NSC Compound Enrichment Correlation
NSC 651853 Null 0.0421163101172308 0.54427416
NSC 653860 Null 0.0421163101172308 0.69285978
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0421163101172308 0.80085556
NSC 675766 Null 0.0421163101172308 -0.10356016
NSC 676775 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-.beta.-D-xylopyranosyl]- 6-deo 0.0421163101172308 -0.21999818
NSC 680300 Null 0.0421163101172308 0.28541004
NSC 681639 Camptothecin Derivative 0.0421163101172308 0.70728439
NSC 683662 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo 0.0421163101172308 0.16484896
NSC 684902 Null 0.0421163101172308 0.38761358
NSC 685005 Null 0.0421163101172308 -0.16894688
Total:66  Current:58    [First] [Prev] [Next] [Last]